Oncternal Therapeutics ( NASDAQ: ONCT ) is scheduled to announce Q1 earnings results on Thursday, May 9th, after market close. The consensus EPS Estimate is -$2.88 and the consensus Revenue Estimate is $0.
13M (-35.0% Y/Y). Over the last 3 months, EPS estimates have seen 1 upward revision and 1 downward.
Revenue estimates have seen 1 upward revision and 0 downward. More on Oncternal Therapeutics Historical earnings data for Oncternal Therapeutics Financial information for Oncternal Therapeutics.
